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Objectives: Many health promotion campaigns and interventions focussing on improving
health-related behaviours have been based on targeting response efficacy. This is based on
the assumption that response efficacy is an important modifiable determinant of behav-
iour change. This study aimed to quantify the association between response efficacy and
objective and subjective measures of physical activity and diet.
Study design: Prospective cohort analysis of data from a randomised controlled trial.
Methods: A total of 953 participants were assessed for response efficacy at baseline and 12
weeks following randomisation to interventions to increase physical activity and improve
diet. Subjective measures were collected via a self-report questionnaire that included two
questions used to derive the Cambridge Index of physical activity and questions about
daily or weekly fruit and vegetable, whole grain, meat and fish intake, based on the dietary
guidelines to lower cardiovascular risk. Objective measures were quantified using accel-
erometers and plasma carotenoids.
Results: The mean change in response efficacy for physical activity was þ0.5 (standard
deviation [SD] 2.0) and for diet was þ0.5 (SD 2.1).There were no clinically or statistically
significant associations between baseline or change in response efficacy and objective and
subjective measures of physical activity or objective measures of diet. There was a small
statistically significant association between baseline response efficacy and change in self-
reported wholegrain consumption, but this is unlikely to be clinically significant.
Conclusions: Response efficacy is not a fundamental determinant of diet and physical ac-
tivity and should not be the main focus of interventions targeting these behaviours.
© 2018 The Author(s). Published by Elsevier Ltd on behalf of The Royal Society for Public
Health. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).93.
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Premature morbidity and mortality from non-communicable
diseases are significant public health problems.1 Numerous
observational studies have demonstrated the extent to which
modifiable behavioural risk factors, such as physical inactivity
and an unhealthy diet, contribute to the aetiology of many
non-communicable diseases,1e3 with dietary risks accounting
for 10.8% of all causes of disability-adjusted life years in En-
gland and physical activity approximately 3%.1
A number of models have been developed to clarify the de-
terminants of health-related behaviours and inform develop-
ment of interventions. These include theHealth BeliefModel,4,5
Protection Motivation Theory5,6 and the Extended Parallel Pro-
cess Model.7,8 One component common to many of these
models is response efficacy: the belief that an intervention or
action is effective against a perceived health threat8 or that
changing a behavioural risk factor increases or decreases the
risk of developing a disease, for example, increasing physical
activity or improving diet reduces the risk of developing car-
diovascular disease. Although response efficacy is only one
behavioural construct in determining behaviour, understand-
ing the independent role of response efficacy is importantwhen
designing public health interventions. There is a large body of
evidence reporting an association between response efficacy
and intention to change behaviour.8e11 However, the findings
aremoremixed for associations between response efficacy and
behaviour change with some studies reporting a positive asso-
ciation,8,12,13 while others do not.14e17 Many of these existing
studies include small samples of selected populations, such as
young women or undergraduate students,18e20 and all use self-
report measures of behaviour. To our knowledge, there are no
studies that report the association between response efficacy
and objective measures of behaviour change.
The Information and Risk Modification (INFORM) trial is a
randomised controlled trial evaluating the impact of
providing phenotypic and genetic coronary heart disease
(CHD) risk scores alongside a web-based lifestyle intervention
on health-related behaviours, emotional well-being and other
CHD-related risk factors.21 In addition to subjective measures
of behaviour change, it included objective measures of phys-
ical activity and diet. In this study, we aimed to quantify the
association between response efficacy and change in response
efficacy with change in both objectively and subjectively
measured physical activity and diet.Methods
Participants
Full details of the design and methods of the INFORM trial
have been reported previously.21 This present study included
data from 953 male and female blood donors for whom in-
formation about baseline characteristics was available. Par-
ticipants in the INFORM trial were recruited as a convenience
sample via email invitation of participants in the much larger
INTERVAL trial of different intervals between blood dona-
tions.22 To be included in the INTERVAL study, participantshad to be aged 18 years, be eligible to donate blood based on
the NHS Blood and Transplant guidelines at a permanent NHS
Blood and Transplant donor site throughout the trial period
and be able to access the internet. Participants in the INFORM
trial were aged 40e84 years, able to give informed consent,
had no previous medical history of cardiovascular disease,
willing to wear a physical activity monitor (accelerometer) for
7 days, willing to provide a blood sample, agreeable to study
staff sharing their clinical information with their general
practitioner, had a good comprehension of written and verbal
English, were not pregnant, had no contraindication to un-
dertaking physical activity and were not enrolled in a clinical
trial concerning cardiovascular risk or lifestyle interventions
(e.g. diet, physical activity or smoking cessation). To identify
those who were enrolled in a clinical trial concerning cardio-
vascular risk or lifestyle interventions, all participants were
asked in the screening and consent form if they were taking
part in a clinical trial other than INTERVAL.
The participants were stratified by age (60 years) and sex
and randomised to the following four groups using a com-
puter programme within the INTERVAL study database:21
1. Control group (no lifestyle or risk advice given),
2. Given web-based lifestyle advice only,
3. Given web-based lifestyle advice and phenotypic infor-
mation on CHD risk,
4. Given web-based lifestyle advice plus phenotypic and ge-
netic information on CHD risk.
Design
In the present study, data from the four groups were pooled
into a prospective cohort and adjustment was made for the
trial group and other potential confounders during the anal-
ysis. Participants were followed up for 12 weeks.
Measures
Response efficacy
We measured response efficacy at baseline and follow-up (12
weeks after randomisation) using six questions: three relating
to physical activity and three relating to diet. Participants
were asked how strongly they agreed with the following
statements, ‘If I were to be active at amoderate intensity for at
least 30 min per day on at least five days a week, I would
reduce my risk of having coronary heart disease’, ‘Being
physically active is effective in preventing coronary heart
disease’, ‘If I am physically active, I am less likely to have
coronary heart disease’, ‘If I were to consume five servings of
fruit and vegetables each day, I would reduce my risk of
having coronary heart disease’, ‘Eating a healthy diet is
effective in preventing coronary heart disease’ and ‘If I eat a
healthy diet, I am less likely to have coronary heart disease’.
Questions were based on Sanderson et al.'s study, which re-
ported a Cronbach's alpha of 0.84,23 and were similar to those
used in other published studies measuring response effi-
cacy.24,25 Responses were on a five-point scale: ‘strongly
disagree’; ‘disagree’; ‘not sure’; ‘agree’ and ‘strongly agree’.
Responses for physical activity and diet were analysed sepa-
rately. The scores for each of the three questions were
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activity or diet response efficacy 3e15. Change in response
efficacy was calculated by subtracting the response efficacy at
baseline from response efficacy at follow-up.
Physical activity
Physical activity was measured over 7 days at baseline and
follow-up (12 weeks after randomisation) using the wrist-
worn Axivity AX3 3-Axis Logging Accelerometer® posted to
participants with accompanying instructions. In total, 183
participants had undergonemeasurement using this device as
part of the INTERVAL trial in which case these data were used
as baseline measurements for the INFORM trial. Average ac-
celerations (expressed in relative gravity, milligravity [mg])
were measured over the 7-day observation period. Partici-
pants were advised that the accelerometer should be worn
throughout the day and night, including during washing and
bathing, and they should continue their normal activities. We
excluded participants who wore the accelerometer for less
than 24 h at baseline or follow-up. Change in physical activity
was calculated by subtracting the baseline accelerations from
the follow-up accelerations.
Self-reported physical activity was assessed at baseline
and follow-up using the validated Cambridge Index.26 This
categorises participants into four groups: ‘inactive’; ‘moder-
ately inactive’; ‘moderately active’ or ‘active’, depending on
their responses to two questions based on the levels of
occupational physical activity and how many hours spent
per week walking, cycling or doing physical exercise such as
recreational sports. Individuals with a sedentary occupation
were categorised as inactive if they reported zero hours of
activity per week, moderately inactive if they reported up to
3.5-h activity per week, moderately active if they reported
>3.5 and  7 h of activity and active if they reported >7 h of
activity; individuals with a standing occupation were cat-
egorised asmoderately inactive if they reported zero hours of
activity per week and moderately active or active if they re-
ported 3.5 h or >3.5 and  7 h of activity, respectively; in-
dividuals doingmanual workwere categorised asmoderately
active if they reported zero hours of activity and active if they
reported any activity and those doing heavy manual work
were all categorised as active. For this analysis, these cate-
gories were treated as if the distance between categories was
equal. The change in self-reported physical activity was
calculated by subtracting the Cambridge Index at baseline
from follow-up.
Diet
Diet was measured objectively using plasma carotenoid
levels, a proxy measure for fruit and vegetable consumption,
one aspect of diet.27 The baseline levels of carotenoids were
calculated using serum blood samples from the INTERVAL
study and at follow-up as part of the INFORM study, 12 weeks
after randomisation.21
Diet was also assessed by a questionnaire at baseline and
follow-up. Diet was divided into fruit and vegetable, whole-
grain, meat and fish intake. The questions were developed for
the INFORM trial based on the dietary guidelines to lower
cardiovascular risk.28 Participants were asked how many
servings of fruit and vegetables and whole grain theyconsumed in an average day, and howmany servings of meat
and fish they ate in a week. Further details of the questions
and the available responses are outlined in Appendix 1. Ex-
amples of the size of servings per type of food were also
included in the questionnaire.
Each type of the subjective diet category was analysed
separately, and the results were categorised according to the
five responses to each question. For the analysis, these cate-
gories were treated as ordinal, with the distance between the
categories assumed to be equal. For example, an increase in
fruit and vegetable consumption from one per day to
twoethree per day was considered the same as an increase
from twoethree to four or from four to five ormore. Change in
self-reported diet was calculated as the change in the category
between baseline and follow-up.
Sociodemographic/other covariables
Before randomisation, in the INFORM trial, baseline data
relating to age, sex, ethnicity, gross annual income and the
highest educational level were collected from participants by
a questionnaire.
Statistical methods
Weused linear regression to analyse the associations between
baseline response efficacy and change in response efficacy
and objectivemeasures of physical activity (accelerations) and
diet (carotenoids). At baseline, response efficacy did not
conform to the assumptions of linear regression, so we used
the squared values. We used ordinal logistic regression to
assess the associations between baseline and change in
response efficacy and the subjectively measured outcomes.
Change in the Cambridge Index and change in consumption of
fruit and vegetables, whole grain, meat and fish were cat-
egorised into three categories: ‘decrease’; ‘no change’ and
‘increase’. We confirmed agreement with the proportional
odds assumption for each model using the ‘omedel’ and
‘brant’ commands in Stata. The coefficients are expressed as
odds ratios (ORs) for the ease of interpretation.
The first model for each analysis was a simple regression.
The second model adjusted for the a priori confounders: age,
sex, income, the highest education level and an original trial
group. A P-value < 0.05 was considered to be statistically sig-
nificant. The sample size was fixed by the INFORM study, and
retrospective power calculations were not undertaken. If
there were more than 10% missing data for an exposure or
outcome variable, we compared the baseline characteristics of
participants to determine if there was any difference between
the two groups. We carried out all statistical analyses using
Stata 14.1 statistical software (StataCorp, College Station,
Texas, USA).Results
The mean age of the participants was 56.7 years (standard
deviation [SD] 8.81); 55.7% were men; 91.4% described that
their ethnicity as white British; the majority had a university
education and a third of the population reported a gross
annual income of more than £40,000 (see Table 1).
Table 1 e Sociodemographic characteristics at baseline
(N ¼ 953).
Characteristic N (%)a
Age in years [mean (SD)] 56.7 (8.81)
Sex
Male 531 (55.7)
Female 422 (44.3)
Ethnicity
White, British 784 (91.4)
White, Irish 16 (1.9)
White, other 35 (4.1)
Other ethnicities (Asian, Indian; black,
Caribbean; mixed, white and Asian;
Asian, other; mixed, white and black
Caribbean/African; black, African;
Chinese, do not know/prefer not to answer)
23 (2.6)
Highest education level attained
None 8 (0.8)
Primary 3 (0.3)
Secondary 402 (42.3)
University 538 (56.6)
Gross annual income
<£5800 20 (2.1)
£5801e£8000 25 (2.6)
£8001e£40,000 501 (52.9)
>£40,000 321 (33.9)
Do not know 81 (8.5)
SD, standard deviation.
a Unless stated otherwise.
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(range 3e15, interquartile range 12e14) for physical activity
and 12 (range 3e15, interquartile range 11e13) for diet. The
mean change in response efficacy for physical activity was
þ0.5 (SD 2.0) and for diet, was þ0.5 (SD 2.1) [Table 2].
Overallmean changes in physical activity and diet between
baseline and follow-up were small but varied considerably
among participants [Table 2]. For physical activity, there was
an average mean decrease of 1.7 mg (SD 7.6) for the objectiveTable 2 e Change (follow-up minus baseline) in the
response efficacy, physical activity and diet.
Variable Mean change (SD)
Response efficacy
Response efficacy for physical activity 0.5 (2.0)
Response efficacy for diet 0.5 (2.1)
Physical activity
Objective physical activity (mg) 1.7 (7.6)
Subjective physical activity
(Cambridge Index group)
0.2 (1.0)
Diet
Carotenoids (mmol/L) 0.5 (1.0)
Self-report fruit and vegetables
consumption (category of
portions per day)
0.3 (0.8)
Self-report grain consumption
(category of portions per day)
0.2 (0.9)
Self-report red meat consumption
(category of portions per week)
0.1 (0.7)
Self-report fish consumption
(category of portions per week)
0.1 (0.6)
mg, milligravity; SD, standard deviation.measure (accelerations) and a mean decrease of 0.2 (SD 0.99)
for the subjective measure (Cambridge Index group). For diet,
there was a mean decrease of 0.5 mmol/L (SD 0.98) in carot-
enoid levels and for self-reported consumption of fruit and
vegetables, grain, meat and fish, there was a mean change of
0.3, 0.2, 0.1 and 0.1 (SD 0.8, 0.9, 0.7, 0.6), respectively.
For change in objectively measured physical activity and
diet, 14% and 20% of participants had missing data, respec-
tively. However, there were no significant differences in
sociodemographic characteristics among those participants
with and without data (data available on request).
There were no associations between baseline squared
response efficacy, or change in response efficacy, and change
in objectively measured physical activity or diet as shown in
Table 3. There were also no associations between response
efficacy or change in response efficacy and change in self-
reported physical activity as shown in Table 4.
However, for self-reported diet, there was a statistically
significant association between baseline response efficacy
and change in wholegrain consumption (OR: 1.10, 95% confi-
dence interval: 1.03 to 1.18, P-value 0.005) but no associations
between the change in response efficacy and change in self-
reported diet, as shown in Table 4.Discussion
Main findings
To our knowledge, this is the first study that examines the
association between response efficacy and objectively
measured physical activity or diet. In this large cohort, there
were no clinically or statistically significant associations be-
tween response efficacy and objectively or subjectively
measured physical activity. There was a small association
between baseline response efficacy and change in self-
reported wholegrain consumption. However, the other asso-
ciations between response efficacy and diet, both reported and
objectivelymeasured,were small andnot clinically significant.
Comparison with existing literature
It is difficult to directly compare the baseline response efficacy
or change in response efficacy found in this study with the
published literature as there is no universal method of mea-
surement. Of the studies that had used a similar scale,14,15,25,29
most had mean baseline response efficacy scores higher than
in this study (ranging from 4.05 to 4.66 for individual ques-
tions), and none reported changes in response efficacy.
The finding in this study of no association between
response efficacy or change in response efficacy and subjec-
tively or objectively measured physical activity is contrary to
the systematic review by Bui et al. in which response efficacy
was positively correlated with self-reported intention and
behaviour.12 However, in that review, the authors only
included studies that investigated the association between the
components of the Protection Motivation Theory and subjec-
tively measured specific aspects of physical activity, for
example strength and balance training, workplace-based ac-
tivity and vigorous physical activity sessions. This discrepancy
Table 3 e The association between baseline response efficacy (squared) and change in response efficacy and change in
objectively measured physical activity and diet.
Variable Model 1 (no adjustments) Model 2 (adjusted for age, sex, income, the
highest education level and original trial group)
b coefficient (95% CI) P-value n Adjusted R2 b coefficient (95% CI) P-value n Adjusted R2
Baseline response efficacy
Accelerations (mg) 0.0004 (0.01 to 0.01) 0.95 794 0.001 0.0001 (0.01 to 0.01) 0.98 792 0.002
Carotenoids (mmol/L) 0.001 (0.0003 to 0.003) 0.11 762 0.002 0.001 (0.0001 to 0.003) 0.07 758 0.005
Change in response efficacy
Accelerations (mg) 0.04 (0.30 to 0.21) 0.74 753 0.001 0.06 (0.32 to 0.19) 0.62 751 0.002
Carotenoids (mmol/L) 0.02 (0.05 to 0.02) 0.34 726 0.001 0.02 (0.05 to 0.02) 0.34 723 0.008
CI, confidence interval; mg, milligravity.
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used in that study around habitual rather than specific
behaviour and the additional use of objective measures that
aremore robust than themeasuresof intention.Thirteenof the
18 studies that measured response efficacy and were included
in the reviewbyBui et al. also included selectedgroups, suchas
universitypsychology studentsorpredominantly femalestudy
groups.16,18,30 A further explanation for the limited number of
studies reporting no association between response efficacy
and behaviour may be publication bias.
We are aware of only one previous study that investigated
the association between response efficacy and dietary out-
comes.29 That study used self-reported measures of a low-fat
diet and path analysis of the ProtectionMotivation Theory and
found positive associations between response efficacy and
reported low-fat diet. We did not measure the consumption of
low-fat food in our study but instead found a small significant
association between response efficacy and reported whole-
grain consumption and no associations for other aspects of
self-reported diet or carotenoid levels.
Strengths and limitations
The main strengths of this study are the large population size
and objective measures used to assess the change inTable 4 e The association between baseline response efficacy a
physical activity (Cambridge Index) and diet.
Variable Model 1 (no adju
Odds ratio (95% CI)
Baseline response efficacy
Change in Cambridge Index 1.01 (0.94e1.08)
Change in fruit and vegetable consumption 1.06 (0.98e1.13)
Change in wholegrain consumption 1.10 (1.03e1.18)
Change in meat consumption 0.99 (0.918e1.07)
Change in fish consumption 1.01 (0.94e1.10)
Change in response efficacy
Change in Cambridge Index 1.02 (0.95e1.10)
Change in fruit and vegetable consumption 1.06 (0.99e1.13)
Change in wholegrain consumption 0.99 (0.93e1.05)
Change in meat consumption 0.97 (0.91e1.03)
Change in fish consumption 1.04 (0.97e1.11)
CI, confidence interval.
yP < 0.05.behaviour which minimises the risk of bias and improves
precision. The participants in this cohort also had a wider age
range and more equal sex distribution compared with previ-
ous studies that recruited university students or mainly fe-
male participants.15,16,18,30 This makes the findings more
generalisable to the population. However, the study popula-
tion was drawn from a convenience sample of blood donors,
who are likely to be healthier (owing to the extensive exclu-
sion criteria for donating blood) and potentially more inter-
ested in their own health than the general population.
Although the levels of physical activity were similar to other
population-based studies using the same type of accelerom-
eter,31 the mean levels of serum carotenoids for participants
in the INFORM study were slightly higher than those in other
studies.32,33 It is, therefore, possible that there may have been
a ‘ceiling’ to howmuch healthier their lifestyle could become,
constraining the likelihood of further changes in diet and
physical activity during this study. The lack of association
between response efficacy and behaviour change may,
therefore, be due to a lack of change in physical activity and
diet across the whole study cohort.
The use of objective measures of outcomes reduced recall
bias and response bias, and the use of accelerometers
continuously in a free-living situation increased the number
of measurements and reduced the risk of random error.nd change in response efficacy and change in self-reported
stments) Model 2 (adjusted for age, sex, income,
highest education level and
original trial group)
P-value n Odds ratio (95% CI) P-value n
0.71 945 0.99 (0.92e1.07) 0.88 940
0.13 856 1.03 (0.97e1.12) 0.31 852
0.004y 856 1.10 (1.02e1.17) 0.008y 852
0.76 856 1.01 (0.93e1.08) 0.90 852
0.71 856 1.00 (0.93e1.09) 0.82 852
0.62 856 1.03 (0.95e1.10) 0.52 852
0.07 856 1.05 (0.99e1.12) 0.11 852
0.64 856 0.98 (0.92e1.04) 0.48 852
0.34 856 0.97 (0.91e1.04) 0.38 852
0.30 856 1.02 (0.96e1.10) 0.49 852
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enoids have a strong correlation with fruit and vegetable
intake, so are a good objective measure of these aspects of
diet27 but not, for example, the consumption of whole grains.
Our finding of an association with wholegrain consumption
could also be the result of multiple hypotheses testing so
should be interpreted with caution.
There is also no ‘gold standard’measurement for the latent
variable response, making any measurement scale difficult to
validate. However, the questions used in this study have been
used previously,23,29 and the impact of response bias was
minimised by using the same questionnaire at baseline and
follow-up.
By focussing on response efficacy alone, we have also only
investigated one aspect in a complex system of determinants
of behaviour change and cannot exclude an interaction be-
tween response efficacy and other behaviour change con-
structs. Given the lack of evidence in this area on response
efficacy alone, however, this study provides an important
contribution to the literature on the independent role of
response efficacy in changing behaviour.
Implications for practice, policy and research
There is a growing burden of preventable chronic conditions
associated with unhealthy diets and inactivity. The develop-
ment of effective strategies to influence these behavioural
determinants at the individual and collective level is, there-
fore, a priority for policymakers. We have shown that
response efficacy and change in response efficacy alone are
not associated with change in behaviour. Consequently, in-
terventions that seek to influence the behaviour solely by
targeting response efficacy are unlikely to be effective.
Perhaps, instead interventions might target other behaviour
change components. For example, there is a substantial body
of evidence of associations between self-efficacy and change
in behaviour using both subjective and objective measures of
behaviour change.34e36 Alternatively, interventions based on
frameworks incorporating multiple elements targeting mul-
tiple behaviour change techniques, such as the Behaviour
Change Wheel developed by Michie et al.,37 may be more
effective than those targeting individual variables from spe-
cific psychological models. There is also good evidence that
habitual behaviours such as diet and physical activity are
subject to powerful environmental influence rather than the
result of a conscious cognitive decision-making process.38,39
Consequently, there is growing interest in the potential for
alterations to the environment, from the size of wine glasses
to the introduction of cycle lanes, to positively influence
health behaviours. Other collective approaches that have
proved effective include taxes on sugar-sweetened beverages
inMexico.40 Such population-based approaches to shifting the
distribution of behaviours may be effective when used alone,
as demonstrated in North Karelia,41 or in conjunction with
individual-based approaches, such as in the V€asterbotten
Intervention Programme that incorporated individual cardio-
vascular risk assessment and population-wide strategies.42
Whether a population or individual-based approach for
behaviour change is evaluated, research using samplepopulations that are due to be targeted by interventions is
much needed. In addition, this research should incorporate
precise objective measures, which is lacking in the current
evidence.
In summary, we have identified no association between
response efficacy and change in health behaviours and sug-
gest that targeting response efficacy alone is unlikely to ach-
ieve behaviour change.Author statements
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implications. Glob Health Action 2010;3:1e15.Appendix 1. Questions assessing self-reported
diet
For the following questions please tick the box that applies to
you the most.
How many servings of fruit and vegetables do you
consume on an average day?
(one serving is equivalent to 1 piece of fruit or a standard
glass [200 mls] of unsweetened juice [only one glass counts];
potatoes are not included as a vegetable).
 None
 One a day
 2e3 per day
 4 per day
 5 or more per day
Howmany servings of whole grains do you consume on an
average day? (one serving of whole grain foods include: whole
meal or whole grain bread [1 slice]; wholewheat pasta [2 ta-
blespoons cooked]; wholegrain breakfast cereal [3 table-
spoons] or whole rolled porridge oats [1 tablespoon
uncooked]).
 None
 One a day
 2 per day
 3e4 per day
 5 or more per day
How many servings of red meat (beef, lamb, pork, bacon,
ham, sausages and burgers) do you consume during an
average week? (one serving is equivalent to 80 g, which is
approximately the size of a pack of cards; 2 rashers of bacon or
1 ½ standard size sausages).
Some average serving sizes of red meat (raw weight): me-
dium steak ¼ 145 g (5.1 oz); pork chop ¼ 75 g (2.6 oz); spaghetti
Bolognese with minced beef ¼ 140 g (4.9 oz); serving of roast
beef ¼ 90 g (3.2 oz).
 None
 One a week
 2e3 per week
 4e6 per week
 7 or more per week
How many servings of fish do you consume during an
average week?
(one serving is equal to 140 g of cooked fish, or equivalent in
size to approximately the size and thickness of the palm of
your hand).
 None
 One a week
 2e4 per week
 5e6 per week
 7 or more per week
